Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04677543 · ClinicalTrials.gov registry record · Phase 3
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
A Phase 3 study, sponsored by Insmed Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 99
- Enrollment target
NCT04677543 is a Phase 3 study that has completed, run by Insmed Incorporated. The registered enrollment target is 99 participants.
The verdict
NCT04677543, a Phase 3 study, has completed, sponsored by Insmed Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 99 participants
- Enrollment target
Study Summary
The primary objective of this study is to generate evidence demonstrating the domain specification (via modern psychometric methods), reliability, validity, and responsiveness (within-subject meaningful change) of the Patient-Reported Outcome (PRO) endpoints.
Interventions
- DRUG Azithromycin
- DRUG Ethambutol
- DRUG ALIS
- DRUG ELC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2020-12-22 |
| Est. Completion | 2023-05-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04677543
The ClinicalTrials.gov registry entry for NCT04677543 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insmed Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Azithromycin is the first listed.
NCT04677543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04677543 about?
NCT04677543 is a clinical study titled "Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex". The primary objective of this study is to generate evidence demonstrating the domain specification (via modern psychometric methods), reliability, validity, and responsiveness (within-subject meaningful change) of the Patient-Reported Outcome (PRO) endpoints.
What is the current status of trial NCT04677543?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 99 participants. The study started on 2020-12-22. Estimated completion is 2023-05-09.
What interventions are being tested in trial NCT04677543?
The interventions under investigation include: Azithromycin (DRUG), Ethambutol (DRUG), ALIS (DRUG), ELC (DRUG).
Who is sponsoring clinical trial NCT04677543?
This trial is sponsored by Insmed Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.